The questions addressed in this study include examination of the effect of the dual HDAC/LSD inhibitor 4SC-202 in TNBC on migration, tumor growth and metastasis, as well as addressing the cellular and molecular mechanism of action. Here, HDAC9 is linked to neoplasm.